Name | Value |
---|---|
Revenues | 43.8M |
Cost of Revenue | 26.6M |
Gross Profit | 17.3M |
Operating Expense | 9.9M |
Operating I/L | 7.4M |
Other Income/Expense | 0.2M |
Interest Income | 0.1M |
Pretax | 7.6M |
Income Tax Expense | 1.0M |
Net Income/Loss | 6.6M |
Atrion Corporation develops, manufactures, and sells fluid delivery, cardiovascular, and ophthalmology products globally. Its fluid delivery products include valves for anesthesia and oncology applications, promoting infection control. The company's cardiovascular products comprise a Myocardial Protection System, cardiac surgery vacuum relief valves, silicone vessel loops, and inflation devices for heart bypass surgery. Its ophthalmic products include medical devices for disinfecting contact lenses and balloon catheters for treating nasolacrimal duct obstruction. Atrion also manufactures instrumentation for measuring blood clotting time and safe needle and scalpel blade containment products. The company sells its products to physicians, hospitals, clinics, and other treatment centers, as well as equipment manufacturers.